Pricing Log in Create free account

Harmony Biosciences Holdings, Inc. (HRMY) vs SELLAS Life Sciences Group, Inc. (SLS)

Harmony Biosciences Holdings, Inc. and SELLAS Life Sciences Group, Inc. are both Biotechnology companies. Harmony Biosciences Holdings, Inc. and SELLAS Life Sciences Group, Inc. are of similar size ($2.3B and $2.2B). SELLAS Life Sciences Group, Inc. has negative trailing earnings, so its P/E is not meaningful; Harmony Biosciences Holdings, Inc. trades at 12.2×. Harmony Biosciences Holdings, Inc. has the higher net margin (18.9% vs 0.00%) and the higher return on invested capital (29.7% vs 0.00%). Across the 16 metrics below, Harmony Biosciences Holdings, Inc. leads on 13 and SELLAS Life Sciences Group, Inc. on 3.

Valuation

Metric HRMY SLS Biotechnology median
P/E 12.20 n/m 8.50
P/S 2.31 179.81 9.71
P/B 2.21 13.72 2.13
Price to free cash flow 7.03 n/m 20.82
EV/EBITDA 6.65 n/m 0.64
EV/Sales 1.77 166.67 9.21
Earnings yield 8.19% (2.10%) (33.15%)
Free cash flow yield 14.22% (2.04%) (25.50%)

Profitability

Metric HRMY SLS Biotechnology median
Gross margin 75.42% 0.00% 65.16%
Operating margin 24.03% 0.00% 0.00%
Net margin 18.88% 0.00% 0.00%
Free cash flow margin 36.99% 0.00% 0.00%
Return on equity 20.46% (39.63%) (56.36%)
Return on assets 14.61% (36.54%) (48.04%)
Return on invested capital 29.70% 0.00% 0.00%

Growth

Metric HRMY SLS Biotechnology median
Revenue growth (TTM) 24.25% — 6.02%
EPS growth (last fiscal year) 7.97% 50.00% 30.26%
Revenue growth, 5-year CAGR 40.30% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRMY SLS Biotechnology median
Debt to equity 0.15 0.00 0.00
Current ratio 3.48 18.83 4.72
Net debt to EBITDA (2.63) 2.54 0.96

Dividend

Metric HRMY SLS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HRMY SLS Biotechnology median
Market cap 2.23b 2.29b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack